List of insiders holdings for ENZO BIOCHEM INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
HARBERT MANAGEMENT CORP Harbert Discovery Fund LP HARBERT DISCOVERY FUND GP LLC HARBERT DISCOVERY CO-INVESTMENT FUND I LP HARBERT DISCOVERY CO-INVESTMENT FUND I GP LLC HARBERT FUND ADVISORS INC. BRYANT JOHN F. LUCAS KENAN HARBERT RAYMOND J 10% Owner | 2021-10-28 16:39:47 | 5,175,913 0 | 5,175,913 | Form 13D |
Radoff Bradley Louis Director | 2024-02-02 21:00:56 | 4,390,882 430,000 | 4,820,882 | Form 4 |
Wolf James G. 10% owner until 2/13/2023 | 2023-02-13 21:41:29 | 4,103,970 423,500 | 4,527,470 | Form 4 |
RABBANI ELAZAR CHIEF EXECUTIVE OFFICER | 2021-01-13 21:40:52 | 2,262,208 0 | 2,262,208 | Form 4 |
WEINER BARRY W PRESIDENT AND TREASURER | 2021-01-13 21:44:01 | 1,657,499 0 | 1,657,499 | Form 4 |
RABBANI SHAHRAM K Treasurer, Secretary | 2009-07-06 17:28:25 | 1,622,037 0 | 1,622,037 | Form 4 |
Erfanian Hamid Chief Executive Officer | 2022-11-28 18:27:58 | 1,374,600 0 | 1,374,600 | Form 4 |
COUCHMAN JONATHAN Director | 2024-12-02 16:15:10 | 0 447,237 | 447,237 | Form 3 |
Cannon Kara Chief Executive Officer | 2024-07-24 19:50:46 | 380,412 45,065 | 425,477 | Form 4 |
Perlysky Dov Director | 2021-01-13 21:40:47 | 335,780 0 | 335,780 | Form 4 |
TAGLIAFERRI MARY Director | 2024-02-02 21:01:32 | 312,383 0 | 312,383 | Form 4 |
Bench David Chief Financial Officer | 2022-06-15 16:31:04 | 285,800 10,138 | 295,938 | Form 4 |
BORTZ GREGORY M. Director | 2019-01-18 16:30:27 | 269,045 0 | 269,045 | Form 4 |
KASTEN BERNARD L Director | 2016-03-18 14:41:47 | 257,455 0 | 257,455 | Form 4 |
ENGELHARDT DEAN Executive Vice President | 2007-02-09 12:45:50 | 240,655 0 | 240,655 | Form 4 |
SIAS JOHN B Director | 2008-10-01 08:39:36 | 173,087 0 | 173,087 | Form 4 |
Fischer Rebecca J. Director | 2021-01-13 21:43:13 | 160,434 0 | 160,434 | Form 4 |
Walters Ian B. Director | 2023-02-13 21:40:36 | 155,917 0 | 155,917 | Form 4 |
KELKER NORMAN E Senior Vice President | 2008-09-25 21:12:01 | 110,855 0 | 110,855 | Form 4 |
Eckert Patricia Chief Financial Officer | 2024-07-25 17:23:16 | 100,000 0 | 100,000 | Form 4 |
PULLY STEVEN J Director | 2024-02-02 21:02:10 | 97,095 0 | 97,095 | Form 4 |
DELUCCA JOHN Director | 2008-01-16 20:58:57 | 83,647 0 | 83,647 | Form 4 |
CLEMENS PETER J IV Director | 2020-04-29 20:06:19 | 83,333 0 | 83,333 | Form 4/A |
BLANK FABIAN Director | 2020-04-29 20:19:55 | 83,333 0 | 83,333 | Form 4 |
Kent Stephen B H Director | 2012-01-30 20:42:27 | 58,532 0 | 58,532 | Form 4 |
THALENFELD BARBARA E VP, Corporate Development | 2008-02-06 19:36:44 | 55,550 0 | 55,550 | Form 4 |
GOLDBERG DAVID C VP CorpDev IGM Enz Clin Labs | 2016-03-16 16:37:06 | 47,455 0 | 47,455 | Form 4 |
Hanna Bruce A. Director | 2019-01-04 16:52:34 | 43,632 0 | 43,632 | Form 4 |
O'Brien James Michael EVP of Finance | 2019-01-04 17:02:25 | 33,666 0 | 33,666 | Form 4 |
GERSON IRWIN Director | 2010-03-08 16:56:30 | 31,191 0 | 31,191 | Form 4 |
LAZAR MELVIN F Director | 2010-03-08 16:56:00 | 31,191 0 | 31,191 | Form 4 |
Crescenzo Andrew R. Senior VP of Finance | 2014-01-22 16:57:49 | 29,455 0 | 29,455 | Form 4 |
BALEZENTIS CARL W Pres., Enzo Life Sciences | 2010-12-20 18:13:52 | 25,950 0 | 25,950 | Form 4 |
Conant Marcus Director | 2004-07-19 11:08:22 | 25,198 0 | 25,198 | Form 3 |
KRENITSKY KEVIN President, Enzo Clinical Labs | 2010-02-02 20:15:28 | 17,600 0 | 17,600 | Form 4 |
BASS HERBERT B VP of Finance | 2014-01-22 17:05:44 | 12,273 0 | 12,273 | Form 4 |
Whiteley Andrew P COO, Enzo Life Sciences, Inc. | 2014-01-22 17:04:41 | 12,273 0 | 12,273 | Form 4 |
FISCHETTE CHRISTINE Pres., Enzo Therapeutics, Inc. | 2009-01-26 21:22:40 | 11,500 0 | 11,500 | Form 4 |
WARSHAWSKY STANFORD S 01/2004, Resigned as Director | 2004-05-19 17:42:35 | 0 0 | 0 | Form 4 |